
U.S. MRUS Stock Analysis: Key Factors Driving Stock Gains and Losses, Technical Trends, Future Value, and Investment Strategies※ Merus N.V. (Ticker: MRUS) is a global biotechnology company headquartered in the Netherlands, specializing in antibody-based cancer therapies. Using its proprietary Biclonics® platform, Merus designs and develops bispecific antibodies that aim to overcome the immune ev..

U.S. SABS Stock Analysis: Stock Price Drivers, Decline Risks, Technical Trends, and Investment Strategies※ SAB Biotherapeutics, Inc. (Ticker: SABS) is a biotechnology company specializing in the development of human polyclonal antibody therapies. The company’s proprietary DiversitAb™ platform has the potential to create next-generation antibody therapies that target a wide range of diseases, inc..